← Back to catalogue

OptiScanner 5000 Glucose Monitoring System

FDA UDI

Class II (US FDA UDI)

by Optiscan Biomedical Corporation

Identity

Trade Name
OptiScanner 5000 Glucose Monitoring System FDA UDI
Generic Name
Point-of-care blood glucose monitoring system FDA UDI
Device Name
Automated, in-line, bedside, glucose monitoring system FDA UDI
Model / Reference
5000 FDA UDI
Description
Automated, in-line, bedside, glucose monitoring system FDA UDI

Identifiers

Catalog Number
OPTI-5 FDA UDI
Primary DI / UDI-DI
00850003892504 FDA UDI
510(k) Number
K162042 FDA UDI
FDA Product Code
PYV FDA UDI
LZF FDA UDI
GMDN Term
Point-of-care blood glucose monitoring system FDA UDI

Classification

Device Class
Class II FDA UDI
Regulation Number
862.1345 FDA UDI
880.5725 FDA UDI
Commercial Distribution
In Commercial Distribution FDA UDI

Clinical & Handling

Sterile

No

FDA UDI

Single Use

No

FDA UDI

Implantable

No

FDA UDI

Contains Latex

No

FDA UDI

Prescription Use

Yes

FDA UDI

Over-the-Counter

No

FDA UDI

Convenience Kit

No

FDA UDI

Combination Product

No

FDA UDI

HCT/P

No

FDA UDI

Premarket Exempt

No

FDA UDI

Lot / Batch Number

No

FDA UDI

Serial Number

Yes

FDA UDI

Expiration Date

No

FDA UDI

Manufacturing Date

Yes

FDA UDI
MRI Safety
MR Unsafe FDA UDI

Category: Point-of-care blood glucose monitoring system

OptiScanner 5000 Glucose Monitoring System by Optiscan Biomedical Corporation — Class II — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS

Similar devices

Also classified as Point-of-care blood glucose monitoring system.

Cleared under the same submission

Authorization Coverage (1 country)

Regulatory Authorizations

United States Pending data

FDA UDI

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Sources (1)

  • FDA UDI 85903bd2-c994-4db1-8f6c-a2d72f7da1d0 36 fields · synced May 30, 2026